- Bioactivity drops from 100 percent to near zero
declares having received honoraria from Novo Nordisk, Eli Lilly, Akebia Therapeutics, Ardelyx, Becton Dickinson, Endologix, FibroGen, GSK, Medtronic, Neovasc, Provention Bio, ReCor, BrainStorm Cell Therapeutics, Alnylam and Intarcia for consulting activities, and research funding to his institution from AbbVie, Esperion, AstraZeneca, CSL Behring, Novartis and Eli Lilly
It will remain available as an inexpensive, short-term option, but it will not improve
Ensuring adequate B vitamin levels removes nutritional barriers to nerve repair
Zero complaints and will definitely choose them again should the need arise
I share this because I believe healing is rarely a straight line, and because I suspect many of the people who walk through my door are carrying their own version of a story like mine a fear theyve quietly held, a distance theyve had to travel, a safety theyre still learning to find